Annual Drug Patent Expirations for UPNEEQ
Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
This drug has forty-one patent family members in twenty-eight countries.
The generic ingredient in UPNEEQ is oxymetazoline hydrochloride. One supplier is listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
